Yuki Ouchi Selected Research

WQ-3810

1/2020

WQ-3810: A new fluoroquinolone with a high potential against fluoroquinolone-resistant Mycobacterium tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuki Ouchi Research Topics

Disease

2	Leprosy (Hansen's Disease) 12/2021 - 04/2020
1	Communicable Diseases (Infectious Diseases) 12/2021
1	Tuberculosis (Tuberculoses) 01/2020
1	Salmonella Infections (Salmonellosis) 01/2019

Drug/Important Bio-Agent (IBA)

2	Ofloxacin (Ofloxacine)FDA LinkGeneric 12/2021 - 04/2020
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2020
1	WQ-3810IBA 01/2020
1	Antitubercular AgentsIBA 01/2020
1	QuinolonesIBA 01/2019
1	7- (7- amino- 7- methyl- 5- azaspiro(2.4)heptan- 5- yl)- 6- fluoro- 1- (2- fluoro- 1- cyclopropyl)- 1,4- dihydro- 8- methoxy- 4- oxo- 3- quinolinecarboxylic acidIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2020